ARCHIVES

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

HHS Drops Misconduct allegations Against NCI’s Gallo Days Before Appeals Hearing

November 19, 1993

Also M.D. Anderson awarded three new, one renewal SPORE grant.

October 31, 2003

Toxicology Program Seeks Comment On Substances.

March 23, 2001

CGOP Gets New Life, Will Move T DCT; DCPC May Fund More CCOPs with Money It Saves

July 25, 1986

Six Patients Apparently responded To Laetrile, NCI Review Finds; DCT Considers Clinical Trials

September 8, 1978

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005